Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M84.2Revenue (TTM) $M23.5Net Margin (%)-22.0Altman Z-Score0.2
Enterprise Value $M108EPS (TTM) $-0.1Operating Margin %-35.5Piotroski F-Score3
P/E(ttm)--Beneish M-Score-1.3Pre-tax Margin (%)-36.3Higher ROA y-yY
Price/Book2.110-y EBITDA Growth Rate %--Quick Ratio1.5Cash flow > EarningsN
Price/Sales3.55-y EBITDA Growth Rate %42.7Current Ratio2.7Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-7.2Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-13.4Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M78.0ROIC % (ttm)-17.6Gross Margin Increase y-yY

Gurus Latest Trades with NEPT

Number of guru portfolios checked: 68.
No Entry found in the selected group of Gurus. You can

NEPT is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


NEPT: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Montgomery, Adrian TaylorDirector 2014-12-03Buy11,000$2.21-51.13view
Godin, AndrSenior Officer 2014-11-12Buy3,000$2.15-49.77view
Lemieux, PierreDirector or Senior Officer of Insider or Subsidiar 2014-11-12Buy5,000$2.19-50.68view
Godin, AndrSenior Officer 2014-11-11Buy8,000$2.12-49.06view
Ripplinger, JohnSenior Officer 2014-11-11Buy3,550$2.12-49.06view
Turcotte, MarioSenior Officer 2014-11-11Buy6,870$2.14-49.53view
Fitzgibbon, PierreDirector 2014-11-10Buy37,500$2.09-48.33view
Huart, BenoîtDirector 2014-11-10Buy7,000$2.03-46.8view
Lauzon, ClaudieSenior Officer 2014-11-10Buy2,400$2.08-48.08view
Le Bel, DominiqueSenior Officer 2014-11-10Buy10,000$2.01-46.27view

Press Releases about NEPT :

Quarterly/Annual Reports about NEPT:

    News about NEPT:

    Articles On GuruFocus.com
    What Drives St. Jude Medical to Be More Diversified? Apr 30 2014 

    More From Other Websites
    Neptune Technologies & Bioresources, Inc. :NEPT-US: Earnings Analysis: Q1, 2017 By the Numbers :... Jul 22 2016
    Acasti Announces the Election of its Directors, Change of Fiscal Year End and Other Related Matters... Jul 15 2016
    Neptune Announces the Election of its Directors and Change of Fiscal Year End Jul 15 2016
    Neptune Announces First Quarter Results 2017 Jul 12 2016
    Neptune Tech reports 1Q loss Jul 11 2016
    Neptune Tech reports 1Q loss Jul 11 2016
    Acasti Announces First Quarter Results Jul 11 2016
    Neptune Announces First Quarter Results Jul 11 2016
    Neptune to Hold Conference Call to Discuss First Quarter Results for the Period Ended May 31, 2016 Jun 30 2016
    Neptune Technologies & Bioresources, Inc. :NEPT-US: Earnings Analysis: Q4, 2016 By the Numbers :... Jun 24 2016
    NEPTUNE TECHNOLOGIES & BIORESSOURCES INC. Financials Jun 03 2016
    Neptune Tech posts 4Q profit May 25 2016
    Neptune Tech posts 4Q profit May 25 2016
    Acasti Announces Fourth Quarter and Fiscal Year Results May 25 2016
    Neptune Announces Fourth Quarter and Fiscal Year Results May 25 2016
    Neptune to Hold Conference Call to Discuss Fourth Quarter and Year-End Results May 13 2016
    Jan D'Alvise Appointed President & CEO of Acasti Pharma May 12 2016
    Neptune Announces Term Loan Financing Apr 20 2016
    Neptune Announces Term Loan Financing Apr 20 2016
    Neptune Announces Preliminary Q4 Results Record Revenue and Positive Adjusted EBITDA Apr 05 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)